Podcasts about Medtronic

Ann Latham is the author of The Power of Clarity and founder of the consulting firm Uncommon Clarity®. Her clients represent over 40 industries and range from organizations such as Boeing, Hitachi, and Medtronic to non-profits such as the Public Broadcasting Service, the United Way, and colleges and universities. Ann's advice has appeared in publications such as The New York Times, Bloomberg, and Forbes.com. Mentioned in this Episode:Ann on LinkedIn - https://www.linkedin.com/in/annlathamuncommonclarity/AnnLatham.com - https://annlatham.com/Find all of Ann's books - https://annlatham.com/books-by-ann-latham/Time Codes:(0:15) -  Introduction to Ann Lathan(1:45) - How do you define clarity?(3:29) -  How did you become an authority on clarity?(6:08) - What is true clarity?(9:35) - What is a treadmill verb and what are some examples? (10:50) - How do you avoid using words like ‘review' as hiding spots or stalling places? (14:24) - do you have a recommended pre-meeting process to get everyone on the same page?(17:48) - What is the S.O.A.R. decision-making method?(23:29) - Can you explain ‘wandering in' and how it relates to decision-making?(28:00) - What does the start of your day look like?(28:57) - Is your approach based on the book “Getting Stuff Done”?(31:48) - What does your tool look like for capturing and organizing the bigger picture?(33:18) -  How much time does it take to stay organized?(34:50) -  What are the elements that make sifting and organizing more practical?(41:44) -  What other tips do you have for reducing distractions? (44:07) - What are you sick of talking about? (46:26) - Would you argue that every business interaction has to be purely focused and objective?(50:56) - How can people find you?

Bill George joins us to share his insights on authentic leadership–the theme of the latest edition of his best-selling book True North: Emerging Leader Edition.  Bill is the former chairman and CEO of medical-device company Medtronic and the author of four best-selling books on leadership. He is currently an Executive Fellow at Harvard Business School, where he's taught leadership since 2004. Bill currently serves on the boards of Goldman Sachs and the Mayo Clinic, and he is a trustee of the World Economic Forum. Bill recently published a new edition of True North that focuses on emerging leaders. He joined us for an online event with Carolyn Dewar, a senior partner in our San Francisco office who co-leads our CEO Excellence practice and co-authored the New York Times bestseller, CEO Excellence.   Join our LinkedIn community of more than 87,000 members and follow us on Twitter at @McKStrategy.  Explore more Inside the Strategy Room episode transcripts on McKinsey.comSee www.mckinsey.com/privacy-policy for privacy information

In this week's episode, CEO Kevin Sayer takes a few minutes to share Dexcom's vision for the future OUTSIDE of diabetes. What does this mean for people with diabetes and others who could benefit from the powerful Dexcom G7? We also bring in a very popular interview from our MedtronicTalks podcast series – Skip Kiil, president of cranial and spinal technologies, shares some very wise career advice that helped him accelerate his career. He also talks with Tom Salemi about his move to Medtronic and how the company is ramping up to dominate the spinal and cranial spaces. His interview is sponsored by Allied Motion Technologies. Chris Newmarker, executive editor of life sciences at MassDevice shares his Newmarker's Newsmakers including Dexcom, Medtronic, Masimo, Philips, Abbott and Shockwave. Thanks for listening to the DeviceTalks Weekly Podcast. You can subscribe to the DeviceTalks Podcast Network on any major podcast player.

Episode: 116Today's guest on Your Purposeful Life with Adrian Starks is Former Blue Man and Professional Clown turned Communication Trainer and Pro Speaker, Don Colliver.Join us on this episode as I speak with guest Don Colliver who shares his journey of becoming a blue man and professional clown and then reshaping his purpose to now being a communication trainer and pro speaker helping companies such as Google.  Watch the full video of this episode on our YouTube channel available Saturday January 21st:  https://youtube.com/@adrianstarks

The power of clarity represents your greatest untapped opportunity for achieving greater results with increased confidence and commitment — this is the message of today's guest in her book, The Power of Clarity. She's also the author of Uncommon Meetings, The Disconnect Principle, and The Clarity Papers. This episode features Ann Latham, President of Uncommon Clarity. She's on a mission to fight the disclarity that erodes our productivity and performance and that of our team members. As President of Uncommon Clarity, she's helped clients in more than 40 industries from large corporations like Boeing and Medtronic to nonprofits like PBS and the United Way.In this episode, Ann and Ethan discuss: Why the emotional component of customer experience is so importantHow clarity factors into a positive or negative customer experienceWhat is a specific definition of clarity and dis-clarity?How cognitive load specific movements can help boost productivityHow specificity, process, focus and clarity work togetherMore information about Ann and today's topics:LinkedIn Profile: https://www.linkedin.com/in/annlathamuncommonclarity/Company Website: https://www.uncommonclarity.com/Relevant Links:Check out Ann's Books here: https://www.amazon.com/stores/Ann-Latham/author/B004VSGMT0?ref=ap_rdr&store_ref=ap_rdr&isDramIntegrated=true&shoppingPortalEnabled=truehttps://disconnectprinciple.com/https://annlatham.com/Subscribe, listen, and rate/review the Customer Experience Podcast on Apple Podcasts, Spotify, Amazon, or Google Podcasts, and find more episodes on our blog.

Pristine Surgical CEO Bryan Lord spent his career advising and investing in medical device companies, so he didn't immediately see how a “conspicuous outsider” like himself would be the right person to serve as CEO of start-up Pristine Surgical. But he immediately recognized the satisfaction in leading the company's work to create first-of-its-kind 4K single-use surgical arthroscope designed for arthroscopic procedures. After securing 510(k) notification from the FDA, Pristine Surgical is ready to compete in the rigid endoscope market serving orthopedics and general surgery. Lord explains how Pristine can lower costs and improve efficiencies with the new tech and sales model. He also explains how Pristine expects to compete in the much larger flexible endoscope market. Chris Newmarker, executive editor of MassDevice, returns with his Newmarker's Newsmakers featuring Verily, Medtronic, Sterigenics, CardiacSense, Masimo, and Philips. Our DeviceTalks Weekly Fastball returns with a pitch from FluidIQ. And to hear the entire interview with Steve Oesterle, go here. https://www.devicetalks.com/can-moon-surgical-fill-critical-role-in-the-or-analyst-matsons-take-on-jj-medtronic-and-more/ Thank you for listening to DeviceTalks Weekly. You can subscribe to the podcast on any major podcast application.

Today we are joined by our very special guest, Bill George, making his second appearance on the show; he is a Professor over at Harvard Business School, the Former CEO of Medtronic, former EVP of Honeywell, and a former board member of Target, Goldman Sachs, Exxon Mobil, Novartis, and the World Economics Form USA. As one of the most recognizable leaders in the world, Professor George joins us to discuss how leaders and teams can effectively build during down markets, the leadership situation at Twitter, and how to coach your team.Learn More About the Emerging Leader Edition of True North :  https://amzn.to/3jYmoMP Twitter of Host (Shamus Madan): @mbitpodcastTwitter of Guest (Bill George): @Bill_George

Technologies including AI, robotics and customized implants creates new opportunities for Medtronic's growing Cranial and Spinal Technologies business. In this episode, Skip Kiil, president of the business unit, explains how his group is deploying technology to drive future growth. Kiil, a former professional baseball player before turning to medtech, also shares critical advice to young medical device executives who are looking to gain relevant experience rapidly. This episode is sponsored by Allied Motion Technologies. Thank you for listening to the MedtronicTalks Podcast. You can subscribe to this podcast on any major podcast application.

Our anchors begin today's show breaking down the recent revaluation across tech stocks with CNBC's Dom Chu and NYU Stern School of Business Professor Aswath Damodaran. Then, Medtronic CEO Geoffrey Martha discusses biotech advancements in 2023, and our Julia Boorstin explores potential catalysts for the media sector. Next, we cover crypto exchange Coinbase cutting 20% of its workforce with CNBC's Kate Rooney and MoffettNathanson Partner Lisa Ellis. Later, Novartis CEO Vasant Narasimhan offers his outlook for health care, and CNBC's Seema Mody reports on large institutional investors betting big on China.

Our guest this time is Sylvia Bartley. She grew up in England and, after college, entered a career in clinical research. Along the way she joined Medtronic where she held positions in sales and marketing. Later she became interested in deep brain stimulation which lead her to combine past clinical experiences with her sales and marketing knowledge.   You will get to hear Sylvia tell her story including how she moved through several jobs to a place where, as she will tell us, she transitioned more to a social orientation working to help different minority groups and, in fact, all of us to benefit from the medical advances she helped to bring about and introduce socially to the world.   Sylvia left Medtronic earlier this year. She will tell us of her plans and desires. I promise that Sylvia's time with us is inspiring and well worth your hearing. You can even visit her website where you can hear her own podcast. Enjoy Silvia and be inspired.     About the Guest: Sylvia Bartley is a health equity thought leader and influencer widely recognized as a neuroscientist, an advocate, and champion of social change, dedicated to advancing health equity through addressing barriers to care for minoritized communities and by addressing the social determinants of health. Sylvia's work is guided by a greater spiritual purpose rooted in mindfulness and intentionality.   She has dedicated most of her professional career to creating opportunities for individuals living with chronic diseases to receive access to medical technologies. For the last 20 years, Sylvia has worked for Medtronic, the world's leading healthcare technology company, where she has held roles in sales, marketing, physician education, and philanthropy. During this time, Sylvia has led global teams to disseminate best surgical practices, advanced techniques, and products to treat Parkinson's Disease and other movement disorders. Most recently, Sylvia helped Medtronic develop an enterprise-wide health equity strategy aligned with customer interests, challenging disease states, and patient needs.   As part of this work, Sylvia engages healthcare leaders, patients, and other stakeholders to uncover and address barriers patients face in receiving high-quality treatment for chronic illnesses. Her commitment to this effort promises to help transform how minoritized communities work with their healthcare providers to manage their chronic conditions.   Her dedication to reducing healthcare disparities extends to her civic engagement. She provides minoritized communities with information and resources to help them make informed choices about critical conditions linked with social determinants of health (SDOH), including education, housing, economic stability, and environmental factors. She employs multiple platforms to reach and support communities, including board memberships with the African American Leadership Forum, the Association of Black Foundation Executives, and The Johnson Stem Activity Centre. She is also an advisory member for the Wallace H. Coulter Department of Biomedical Engineering for Georgia Tech and Emory University and a Regent for Augsburg University in MN.   Sylvia took her work to a new platform when she published her first book, “Turning the Tide: Neuroscience, Spirituality, and My Path Toward Emotional Health,” which outlines the links between our brains and our souls while inspiring readers to change the world with that knowledge.   During her spare time, Sylvia hosts a long-standing weekly community public affairs radio show and podcast, The More We Know Community Show. She interviews change-makers who level the playing field for all minorities by breaking barriers in their careers, lives, and communities.   Sylvia has been recognized with numerous awards, including the Top 100 Most Influential and Powerful Black Briton awards, in 2022, 2021, 2020, and 2019. In 2021, she was awarded the Medtronic HR Stewardship Award and earned recognition for her service and commitment to the Twin Cities in 2020 with the African American Leadership Forum Community Award. Women in Business Award in 2017, and Diversity in Business Awards in 2013 from Minneapolis/St. Paul Business Journal. Sylvia is also a 2014 Bush Fellow and AARP/Pollen's 50 over 50 award recipient.   Sylvia earned a Ph.D. in Neurophysiology from St. Barts and The Royal London School of Medicine and Dentistry and holds a bachelor's degree in Pharmacology from the University of London.       About the Host: Michael Hingson is a New York Times best-selling author, international lecturer, and Chief Vision Officer for accessiBe. Michael, blind since birth, survived the 9/11 attacks with the help of his guide dog Roselle. This story is the subject of his best-selling book, Thunder Dog.   Michael gives over 100 presentations around the world each year speaking to influential groups such as Exxon Mobile, AT&T, Federal Express, Scripps College, Rutgers University, Children's Hospital, and the American Red Cross just to name a few. He is Ambassador for the National Braille Literacy Campaign for the National Federation of the Blind and also serves as Ambassador for the American Humane Association's 2012 Hero Dog Awards.   https://michaelhingson.com https://www.facebook.com/michael.hingson.author.speaker/ https://twitter.com/mhingson https://www.youtube.com/user/mhingson https://www.linkedin.com/in/michaelhingson/   accessiBe Links https://accessibe.com/ https://www.youtube.com/c/accessiBe https://www.linkedin.com/company/accessibe/mycompany/ https://www.facebook.com/accessibe/       Thanks for listening! Thanks so much for listening to our podcast! If you enjoyed this episode and think that others could benefit from listening, please share it using the social media buttons on this page. Do you have some feedback or questions about this episode? Leave a comment in the section below!   Subscribe to the podcast If you would like to get automatic updates of new podcast episodes, you can subscribe to the podcast on Apple Podcasts or Stitcher. You can also subscribe in your favorite podcast app.   Leave us an Apple Podcasts review Ratings and reviews from our listeners are extremely valuable to us and greatly appreciated. They help our podcast rank higher on Apple Podcasts, which exposes our show to more awesome listeners like you. If you have a minute, please leave an honest review on Apple Podcasts.     Transcription Notes Michael Hingson  00:00 Access Cast and accessiBe Initiative presents Unstoppable Mindset. The podcast where inclusion, diversity and the unexpected meet. Hi, I'm Michael Hingson, Chief Vision Officer for accessiBe and the author of the number one New York Times bestselling book, Thunder dog, the story of a blind man, his guide dog and the triumph of trust. Thanks for joining me on my podcast as we explore our own blinding fears of inclusion unacceptance and our resistance to change. We will discover the idea that no matter the situation, or the people we encounter, our own fears, and prejudices often are our strongest barriers to moving forward. The unstoppable mindset podcast is sponsored by accessiBe, that's a c c e s s i  capital B e. Visit www.accessibe.com to learn how you can make your website accessible for persons with disabilities. And to help make the internet fully inclusive by the year 2025. Glad you dropped by we're happy to meet you and to have you here with us.   Michael Hingson  01:21 Hi, everyone, welcome to unstoppable mindset. Glad to see you wherever you happen to be. I am your host, Mike Hingson. And our guest today is Sylvia Bartley, who is a thought leader or neuroscientist. And I'm not going to tell you any more than that, because we're going to make her tell you her whole story. Sylvia, welcome to unstoppable mindset.   Sylvia Bartley  01:41 Thank you, Michael, it's a pleasure to be here with you today.   Michael Hingson  01:45 Well, I was reading your bio. And there is there is a lot there. I know you've done a lot in dealing with diversity and equity and so on. And we'll talk about inclusion and you are a neuroscientist, which is fascinating in of itself. But why don't we start Tell me a little bit about you maybe growing up just how you started and how you got kind of where you are?   Sylvia Bartley  02:06 Yeah, happy to. So where do I start? I think I grew up in the UK, born and bred. And born to two Caribbean parents, my parents are from St. Lucia and Jamaica. And they came to England in the 50s because of the promise of jobs and great access and opportunities. And so they came across they met and they had four children. And growing up in the UK, it was it was a fairly good experience. I won't say the experience racism, or any such thing directly. I was in a predominantly white neighborhood, I went to a very good Catholic school, where I received an excellent education. And I went on to work in the Royal London School of Medicine and Dentistry, where I became a research technician. And I worked there for 13 years. And during my tenure there, I did lots of research on the somatosensory cortex, looking at brain plasticity, and long term potentiation and memory and learning. And so this was a very new field. For me, this was not something I aspire to do. When I was growing up in school, I was very intrigued and very engaged in that particular area in neurophysiology, and I was surrounded by these phenomenal academics and teachers, that really taught me a lot. And during that time, that's when I got my first degree in applied biology specializing in psychopharmacology and my second degree, my PhD in neurophysiology. And again, my work was on the somatosensory cortex, looking at brain plasticity, in response to our experience, our innocuous experience. And I was very intrigued by that work. I'm very intrigued by the the kind of deep, intrinsic pneus of the brain and the function of the brain and obviously, how it really controls everything that we do. But I knew after I did my PhD that I wanted to do some more work that was more clinical facing. And so I left the academic environment and I entered into the medical device field, where I started off in cells, selling wires and stents, interventional cardiology, in the heart of London to the big cardiac centers. And then I quickly transitioned into Medtronic, the large the largest standalone medical device company in the world, and a solid themselves of intrathecal baclofen for B, and then quickly moved to a Furby called Deep Brain Stimulation. And there I was in heaven because that really married the work I did in kind of basic clinical science and, and medicine to the clinical application. And with this therapy And it was approved to be used for patients with Parkinson's disease dystonia, a central tremor. Now, it's for epilepsy OCD. And there's lots of research not approved yet in clinical depression, and other areas. So very taken up. And my work was literally to go to different hospitals that did deep brain stimulation, and train the neurosurgeons and the neurosurgical teams, how to do the DBS procedure, in particular, how to use the advanced technologies that Medtronic brought to this particular Furby. So it was a really fantastic job, it took me too many hours on it, you know, the fabulous surgeons are great minds out there, doing the work. And in addition to that, I met loads of patients and their families, particularly patients living with Parkinson's disease, and when he got to understand their pathway and their experience, and how this therapy really helped to alleviate their symptoms, so it could improve their quality of lives. And that role took me across the United Kingdom. And then, you know, it expanded to Western Europe. So every day, I'll get up and I'll get on a plane to a different country, a different hospital, a different neurosurgical team and spend the best part of my days in a while during a DBS procedure, working with the neurosurgeon and their teams to make sure we disseminate those best procedural practices using the technology. And one of the things I loved about that particular role is I could use the electrophysiological experience that I had in a medical school, doing the single cell recordings in vitro, and do that literally on patients with Parkinson's disease, to identify the brain structures in order for for the physician to locate the lead in an accurate location.   Michael Hingson  06:54 Well, tell me, tell me a little bit more, if you would about deep brain stimulation, what is it? What what do you do? And just kind of help us understand a little bit more about that, if you would?   Sylvia Bartley  07:05 Yeah, sure. So deep brain stimulation is actually a therapy where you apply an a very fine electrode into deep structures of the brain, and the structures that you implant the electrode, they have to be approved structures. So things under the FDA or the to have approval, and you apply chronic stimulation by a an implantable pulse generator that's implanted under the skin, in in the clavicle area. And it's connected by these electrodes and extension cord into that deep structure of the brain. So it's an internal system, it's a medical device that is in is implanted into the patient, and it stays in there. And basically, you control the device and the amount of current that you apply through the electrodes, through the battery through telemetry. And it's been around now for over 35 years. It's proven, particularly in the area of parkinson disease, as I mentioned earlier, it's using other therapy areas, but it really does alleviate the symptoms of these movement disorders. And these movement disorders, they're kind of de neurodegenerative, ie they get worse over time, primarily, not everybody, but most people. So you have the ability to adjust the settings remotely via to military to make sure you're applying the right stimulation. And it's really important that the lead is placed accurately. And that the stimulation is only stimulating that area, because it's surrounded by these other complicated structures. And if you stimulate those areas, you can get side effects that are not, you know, that makes it very uncomfortable and, you know, almost sometimes unbearable. So you've got to be precise in your location, and in your stimulation of parameters, and it's tailored to the patient. Now, this isn't suitable for every patient, there is a selection criteria, the neurologist, the movement disorder, numerologist plays the role in selecting the patients making sure they meet the selection criteria. And they also play the important role of managing the parameters and the stimulation parameters after the lead is implanted. So you're really kind of connected to this device for the rest of your life. It does improve the quality of your life, it's in the right area of the brain and the stimulation parameters are accurate, and you're a right fit for this particular therapy. And it's done all over the world in in many different countries literally, it's probably got approvals in in most countries. Now what I will say is the regulatory approvals are different in every country. So not every condition is approved. But typically, Parkinson disease dystonia is approved throughout the world.   Michael Hingson  09:59 You If so, when the electrodes and the devices is implanted, and you begin to use it, and I appreciate that, you need to clearly know what you're doing. And you need to be very careful. Other than let's take Parkinson's as an example where you are, the visible signs are that you're, you're changing the amount of improper movements or unwanted movements and so on. What is the patient feel?   Sylvia Bartley  10:31 Well, that's a great question. So clearly, before they come to us, they've reached a certain point in their pathway, where the medication is not working well for them, they probably get an imbalance of complications or side effects as opposed to clinical benefits. So it comes to a point in their journey, depending on how far the condition advances, that there is a surgical intervention. And there's many other surgical intervention like vagal nerve stimulation, but deep brain stimulation is one of them. And at the early stages, it was almost like the the very end like you have to be very advanced. But with all the technology, now it can be done kind of earlier in the pathway, but the patients are kind of in a in a bad way, when they get to the point of having deep brain stimulation. And so during the surgery, typically, not always, typically, because the procedure is done in so many different ways. But typically, the patient is awake, there are local anesthesia, Ebenezer daily, they're awake, and they're awake, because when you put the lead in the brain, during the procedure, then you ologists comes in and does what they call physiological testing. So they can apply stimulation during the surgery to make sure that it's really doing what it's supposed to do alleviate the symptoms, and not without any side effects. So they do a battery or test and application of different stimulation parameters. And the patient can respond directly to say, Well, yeah, you know, you can see if the tremors stop in or if the dystonia is, is been averted, but also the patient can tell you how they're feeling.   Michael Hingson  12:14 So they can say things like, and I don't know that you're anywhere near the part of the brain that does that. But you can say things like, I'm hearing a high pitched tone, or I'm hearing a noise or I'm hearing music, which, as I said, may not be anywhere near where you're talking about. But the point is, and I've heard about that before and read about it before, where many times during operations involving the brain, the neurologists would be asking a patient exactly what they sense because, in part, they're mapping different parts of the brain, but they want to make sure that, that they're either getting the results that they want, or they discover something new, which is always helpful.   Sylvia Bartley  12:52 Yeah, exactly. And they do map the brain. And that's why electrophysiological recordings is a good way of doing it. And now we have advanced technologies, there's multiple electrodes that can apply stimulation in different ways. So it really does advance the way in which we do the procedure. But you're absolutely right, we do them up and they make sure they don't get any side effects. For example, your vision, you're near the areas in the brain that is related to your optic nerve, and you want to make sure that they're not getting any double vision or their eyes are not moving towards their nose and sweating is another one. And you know, dystonia putting up the side of the mouth, it is another one as well. So these are very serious side effects that can impact their quality of life. So the goal is to improve it. So making sure that we get the best optimal outcomes. And that's why it's typically done away. But there's now lots of advancements in medical technology and there's lots of research and people looking into doing the procedure asleep. Because it is uncomfortable for the patient. They've got a stereotactic frame on their head, it looks like age, they've got four pins in their head, you know, someone's drilling a 14 millimeter burr hole in their scar while they're awake. So you know, I go to the dentist and having my teeth drilled under local anesthesia is very uncomfortable. So I can't imagine what it feels like when you're in your worst state because the patient is not on medication, because we want them to have the symptoms of Parkinson's. So when we apply this stimulation, and look at me saying we I am so used to saying I want to say they apply this stimulation, you want to see that it's been alleviated. So the patient is not very, not feeling very well anyway, and then they have to go through this procedure, which can last anything from two hours if it's done asleep and experience hand to seven, eight hours. And so it's a long time for the patient. So you know the but the patient is so relieved, grateful and just kind of elated. When the symptoms are alleviated, and their quality of life has been improved, so if I was to like dystonic patients as well, where they have very severe distortion as muscle contractions, and they're, they're in the most kind of painful positions. And it's almost like a miracle, I used to call it the miracle cure, even though it doesn't cure the illness, but it really does alleviate those horrific symptoms that really does impair their quality of life.   Michael Hingson  15:32 Does it have does it have an effect on longevity? If you're using deep brain stimulation? And if it's working, does it? I know, it's not a cure? But does it have any effect on the person's longevity?   Sylvia Bartley  15:46 To be honest, I'm not sure about the return, if there's any recent findings about this, but to my knowledge, no, it doesn't stop or slow down the progression of the condition, alleviates the symptoms. And I haven't looked recently into any research to see if that is different. But you know, for a very long time, there was no evidence to support that it slows it down just improves the quality of life by alleviating the symptoms.   Michael Hingson  16:13 Yeah, so it's dealing with the symptoms, and certainly not the cause. When the surgery is is occurring, or afterward, I'm assuming may be incorrectly but having gone through one just as part of a test many years ago, I assume that there are differences that show up when the brain is stimulated, that show up on an EEG. What do you mean? Well, so if I'm watching, if I'm watching on an electroencephalograph and watching a person's brain patterns, and so on, are there changes when the brain is being stimulated? Can you tell anything from that or is it strictly by watching the patient and their symptoms disappearing or or going away to a great degree?   Sylvia Bartley  16:58 Yeah, so primarily, it's watching the symptoms disappear by but then secondarily, there are new technologies, where we look at local field potentials. And the electrode is connected to an implantable pulse generator that has the ability to sense and monitor brainwaves during the chronic stimulation. And again, this is called local field potentials and sensing. And the idea there is, hopefully to identify when you can stimulate as opposed to applying chronic stimulation to do many things, one, if you can anticipate or identify a marker in the brain. And if you stimulate to reduce that marker, you can reduce the symptoms. And so it's almost like a closed loop, closed loop system. And that will also have an impact on the battery life. Because one of the challenges with deep brain stimulation is you've got to, obviously, it's driven by battery is an implantable pulse generator, we want to make it as small and as powerful as possible to to have clinical effect. And so battery life and longevity is something that's constantly being looked at. And this is a way of reducing the battery, we have rechargeables now, but still, after a period of time, like nine or 10 years, you still have to replace implantable pulse generator, because the battery, you know, life needs to be replenished or changed in one of the not not replenished. But you need to change the battery, because there's no guarantee that it can recharge at the rate that it could before.   Michael Hingson  18:40 So I asked, I asked a question only basically because being a physics guy, I love quantitative things as opposed to qualitative things. And that's why I was asking if there are ways to see differences in in brain patterns and so on. That may be a totally irrelevant question. But that's why I asked the question.   Sylvia Bartley  18:57 Yeah, no, no, not at all. Like I said, sensing is a thing now that they are monitoring and looking for biomarkers and looking at brain activities. While it's in the patient, and that's very advanced, because that hasn't been done before. So yeah,   Michael Hingson  19:13 yeah, it's definitely cutting edge. I'd use that term. It's bleeding edge technology. Yeah, absolutely. In a lot of ways.   Sylvia Bartley  19:21 Absolutely. But you know, I've been out of DBS now for, let's say, six years. So I may not be as common as I used to be. But that's that's the basis and the premise of it.   Michael Hingson  19:32 Well, people have called you a unicorn. What do you think about that and why? I had to ask.   Sylvia Bartley  19:39 And I love that question. And I think they call Well, what they tell me I'm a unicorn is that I have this very diverse background. There's not many people like me, that can talk about Deep Brain Stimulation at the level that I do and have that technical experience and reputation that I did globally to be there. DBS expert. And then secondly, you know, I am this corporate person that worked a lot in marketing and lived in three different countries, very culturally fluid and diverse, and known as a good leader of people, and definitely, with some strong business acumen, but then I think they call me a unicorn, because I'm very much engaged in community, particularly the black community. And as you know, there are many disparities in the black communities or communities of color. And I'm kind of driven, it's just within me to really work and use the skills and connections that I have to help create conditions that everybody thrives in communities, no matter who they are, the conditions they were born into, and their circumstances. And I really live that out, I really work hard in communities voluntarily, to really advance equity, whether it's education, health, or economic, economic wealth. And I do that very seriously. And I think that's really given me a reputation of being a community leader, particularly in Minnesota in the Twin Cities where I live for nine years. I love Minnesota, I love the community. And I really love working in the Twin Cities community to advance equity, because the Twin Cities has one of the largest disparities when it comes to all of those social determinants of health. And for many years, it was ranked the second worst state in the country, for African Americans to live based on the disparities in those social determinants of health. So there is a knowledge and an awareness and a propensity and willingness of many people from diverse backgrounds, to come together to try and solve that, to make Minnesota a great place for everybody to live, work and play. And so really got engaged in that in that arena. And I think that's what really got me my reputation of being not just a corporate leader, but community lead and very passionate about doing that work. And I've also heard that people find it difficult to do both my job was very demanding, it was a global job. I literally traveled globally, even when I was doing philanthropy, but, but when I came back home, just getting seriously engaged in a community and doing it at a serious level, and being very impactful on it. And that's why I think people call me a unicorn, because I have this passion for community, particularly advancing the minoritized communities together with, you know, being a corporate leader and doing that well. And that's my understanding why people call me a unicorn. But also I think, I don't fit into a box, I, when you look at my resume, you say, well, there's a lot on there, I've done a lot, but they're all very different. You know, I've got this passion for emotional Alpha got this passion for neuroscience, I got a passion for community, I've got a passion for philanthropy. I've done marketing and, and strategy and operations. And so you know, I like to blend all of those together, and do the work to advance equity, particularly, in particular health equity. But that is no cookie cutter cookie cutter role, you know, and so that's why I think I'm very kind of unique and different in that way. Well, it's   Michael Hingson  23:19 interesting, you clearly started out with a very technical background. And you have evolved in a sense, if you will, from that, or you have allowed yourself to diversify and to go into other areas, as you said, into marketing and such as that, how did that come about? And you because you, you clearly had carved out a great niche in a lot of specific technical ways. And you clearly have a great technical knowledge. And I'm a great fan of people who can take knowledge from one arena, and and use the skills that you learn from that elsewhere. Like, from being very technical. My master's degree is in physics. And I started out doing scientific things and then, through circumstances went into sales. So I appreciate where you're coming from. But how did you make that transition? Or how did you add that to what you do maybe is a better way to put it?   Sylvia Bartley  24:19 Yeah, I think I just want to go to path and purpose. I think it was just my path. And I was open unconsciously in following my path because I really did not have like a five or 10 year career goal, to say this is my trajectory. But what I did have was passion and love for certain things. And I love neurophysiology. I love working with physicians. I love being in a clinical setting. And I love working in a business environment as well. And I love teaching. When I was on the in the academic institution. I did a lot of teaching. The roles I did initially in a medical device industry was teaching as they call it a sales rep role, but when you're working with therapies, in medical device, you're teaching people a lot about the firm a lot about your devices, the science behind your devices, and you're bringing people together, you're, you're holding meetings. And in order to be an expert, you're constantly learning. And then you're also teaching. And so what I was doing the kind of technical role, I was also very strategic in that, you know, just imagine I was traveling around, let's just say, Western Europe at this point, different countries, and coming across different challenges in a procedure, and noticing, you know, talking to my colleagues that they had the same challenge, and we will problem solve together. And then every day, there's a new challenge, right? So every day, we went to a different procedure, every day, we learned something new because there was a new challenge or something appeared that didn't happen before. And so, in my mind, I wanted to go from a one on one teaching and improvement to how can I do this more strategically? So really thinking across Western Europe to say, how can we teach all these other folks that are also a specialist in these areas, about what we're learning and how to mitigate those challenges that we're having. So that transition for me having to been very technical, with great experience to being a leader of other technical people, where I put together trainings and programs for both staff that were experts, and also physicians, who were doing deep brain stimulation. So we developed a program in Western Europe that's still alive and well today and scaled significantly with young neurosurgeons on how to do the DBS procedure. And so working with physicians from across Western Europe to develop this curriculum, and execute it really well, that it's, again, serving and and really helping to train hundreds of neurosurgeons. You know, it just went from the doing the technical to the teaching, externally and internally, and then also being very strategic, to say, how can we work to improve all of these challenges that we're seeing, and it came, you know, with me moving to Switzerland, to be the procedure solutions, Senior Product Manager for Western Europe, where I really took on this role, and it was very much more strategic. And that's how I got into marketing. I never did an MBA, you know, I did some really great trainings with the Wharton School marketing fundamentals, etc. But I never did a dedicated like two year MBA, but I just learned through experience in and I and re exposure, great leaders to learn from, and it just evolved from there   Michael Hingson  27:45 in sales. What what specifically were you selling? What product   Sylvia Bartley  27:51 sells, so variety of product wise instance? So interventional interventional cardiology, stent, some wires, and that was that was probably the hardest sell, because it's a stent and a wire and there was many companies out there, are you very competitive? So you know, what differentiates yours from another? So I really cut my teeth on sales, selling that product in the Highlander that was highly competitive.   Michael Hingson  28:18 Did you did you? Did you ever have a situation where you were selling and working with a customer? And and I don't know whether this applies to you and what you sold? But did you ever have a situation where you discovered that your product might not be the best product for them? Or would that come up with what you were selling?   Sylvia Bartley  28:40 Um, I gotta say no, because what we what we were selling? No. So if I think about the whys instead, no, because it's a oneness den and anybody that needed to have that procedure, they needed one guy. Now, clearly, there were differences in sizes, and the type of stent, but our stents were very applicable to most situations as as long as we had the appropriate sizes. This would work in terms of intrathecal, baclofen and kind of capital equipment for deep brain stimulation that was very specific to the customer and their needs. And I will, I will say this on a podcast, I work for the best medical device company in the world, of course. And I still stand by that I believe our products are the best in the business, particularly when it comes to deep brain stimulation. We founded this Virpi alongside Professor Bennett bead in Grenoble, in France. In the 1980s. We were kind of the founders of this Philippian and a product we had a monopoly, but over 25 years, I'm not saying that makes us the best but we got the great experience the know how new technology, and I want to correct myself I keep saying we I no longer work for this company, but I've been there for 20 years. So get out of that same so I just want to be very clear to the audience. This is my past role, and I'm not longer work with with them. But again, it was a long time. And I did DBS for about 15 years. So it's very near and dear to my heart. But I do believe they have the best product still today, and are doing exceptionally well, alleviating those symptoms for those particular therapy.   Michael Hingson  30:15 You raise a good point, though, but habits are sometimes not easy to break. It's been 21 years since I worked well, 20 years since I worked for Quantum. And I still say we so it's okay. Thank you, we understand. And I asked the question, because we had products that I sold, that were similar to products from other companies. But there were differences. And sometimes our products might not meet a customer's need. Whereas other products had differences that made them a better fit. And I was just curious to see if you really found that and it sounds like you didn't really have that kind of an issue. And so you had to sell in part based on other things like the reputation of the company, the quality of the company, and other things like that, which, which is perfectly reasonable and makes perfect sense.   Sylvia Bartley  31:09 Yeah, I mean, there's also the kind of referral side of this. And that's where that's where the work is. And the decisions almost have been done, where you have to identify the right patient for the therapy. And then once that is done, and the patient is selected, then it's which device, you know. And at that point, our devices is suitable for all patients that knee deep brain stimulation.   Michael Hingson  31:31 Yeah. So you're, you're going at it in a different way, you need to find the people who had fits in that makes perfect sense. Well, what really caused you to have that? Well, let me ask you something else. First, I, well, I'll ask this, I started and I'll finish it, what would cause you to have the drive and the passion that you have now for more of a social kind of connection and moving into more dealing with social issues, as it were?   Sylvia Bartley  32:00 Well, you know, as a well, let me put it this way. When I was working, doing all of this therapy, traveling the world   Sylvia Bartley  32:12 1000s of DBS procedures, and working with lots of people, I didn't come across many people of color that were receiving these therapies, for whatever reason, and it kind of strikes me as odd. Because it, it shouldn't be a phobia for the privilege, it should be a phobia for everybody. And, you know, United States insurance, and access has a lot to do with that, and outside the United States. You know, I still didn't see it. So anybody, actually, I think I probably saw two black people receiving this burpee. So I've always been mindful of things like that. And obviously, as a black person, I'm very mindful and aware of disparities and discrimination. And I've always had a heart to address discrimination, or not discrimination, equity, as I mentioned earlier on in a discussion. So I've always looked at the world through that lens, in everything that I do. And I always try and do whatever I can, to to help or advance equity. It's just something that will never leave me. And so you know, even at the tender age of 27, when I was a single parent of two children, I got engaged in community, I became the Chair of a large nonprofit that provided subsidized childcare for lone parents. And I did that because there was discrimination in their practices against people of color. And I really wanted to help advance that work by helping to develop policies and programs and a culture, you know, was for everybody. And I worked with the NHS, the non executive team voluntarily, I was a lay chair for the independent review panel, looking at cases where people complained against the NHS for lots of things, including discrimination. But that wasn't the only kind of topic. And it's just work that I continue to do. And when I moved to United States, I just got deeply involved in that as well. So it came to the point after 15 years in in one kind of area of expertise, where I had my foot in both camps of foot in the community, working lots of nonprofits voluntarily to doing the work in a corporation. And really, you know, always wondering how I can marry the two or should I cross over and go deeply into community work. And five years later, here I am, I've left the corporation and I'm taking a little bit of a break, but I really want to get back into working for a nonprofit, close to community Either he's advancing equity, hopefully in health, or around those social determinants of health. So it's just something that's been a red thread throughout my career in life. And I really want to double down on it now, at this point in my career, this point in the world where everything is super crazy, and polarize, and really do whatever I can, and leverage my experience, in healthcare, in community in philanthropy, to advance equity for everybody.   Michael Hingson  35:29 So you mentioned NHS and NHS is what   Sylvia Bartley  35:32 I'm sorry, NHS is a national health service in the UK, it's valuable for data that provides a health service where you pay a nominal amount if you're working. I forget what the percentage is, but you pay a very tiny amount that comes out of your salary, you don't even notice it. And everyone has access to health care.   Michael Hingson  35:51 Got it? So when did you leave med tech?   Sylvia Bartley  35:54 I left my tech at the end of June this year to only recent, this recent Yeah. Hi, gosh.   Michael Hingson  36:03 So what are you doing now? Or are you are working for anyone or you just took a break for a little while to recoup and reassess?   Sylvia Bartley  36:11 Yeah, I've taken a little bit of a break. It's amazing how tired I've been I you know, I've been working really hard globally for the last God knows how many years 3030 plus years. So just welcomed a little bit of a break. Yes, I am looking for other opportunities again, in primarily in a nonprofit space to do the community poster community where wherever I apologize with advancing equity minoritized communities that hopefully, health equity. So I'm looking at doing that. And yeah, we'll just see what happens. But at the moment, I am volunteering at a fabulous nonprofit organization here in Atlanta, called the Johnson stem activity center. It's an organization that was founded by Dr. Lonnie Johnson. He's an inventor of the Super Soaker. And they run some phenomenal programs, robotic programs, computing, computer programs, egaming, coding, virtual reality for students, but particularly for minoritized communities. In this particular center, they give them access to equipment and resources and teams to really get engaged in STEM through these programs. And I just love working. Now unfortunately, I don't live too far away. I go there during the week, and I work with Dr. Johnson and Linda Moore, who oversee this organization together with other entities, and is really taken aback because it's a heart of Atlanta, it's very community driven. And they're doing some excellent work. And to see the young students, particularly those from minoritized communities, build robots and their eyes light up when they're talking about STEM, and what they want to be like an astronaut or cybersecurity, you know, it's just, it's just amazing. So that takes up a lot of my time together with networking, and, you know, socializing. So, and that's what I'm doing right now.   Michael Hingson  38:08 So are you in Atlanta or Minneapolis? Now, Minneapolis?   Sylvia Bartley  38:12 I've been here two years. Yes. Okay.   Michael Hingson  38:15 So you don't get to have as many snowball fights in Atlanta, as you did in Minneapolis. St. Paul?   Sylvia Bartley  38:20 Yeah. No. And it was too cold to have snowball fights. Yeah.   Michael Hingson  38:29 Well, you know, it's, it's one of those subjects worth exploring? Well, I have to ask this just because I'm, I'm curious and as you know, from looking at me a little bit, dealing a lot with with disabilities, and so on. So with the with the organization that you're you're volunteering with, and as they're creating games and so on, do they do anything to make the things that they do inclusive, accessible, safe for people who happen to be blind or low vision or have other disabilities? Has that been something that they've thought about or might be interested in thinking about? Because clearly, if we're really going to talk about inclusion, that's an area where we tend to generally as a society missed the mark.   Sylvia Bartley  39:14 Yeah, absolutely. Inclusion, you know, includes people with disabilities. It sure. Yeah, absolutely. So I think we are set up for that. I don't know we have any students that fall into that category, to be honest, because there's anything from 5000 to 10,000 students that pass through that center per year, but it's definitely something I will go back and ask them about, but I know the facilities itself is is accessible for everybody. So   Michael Hingson  39:48 well. Accessibility from a physical standpoint is part of it. Yeah, but but then you've got the other issues like documentation and other things for a blind person for example to read but the the reason And I'm bringing up the question is, a lot of times, and I'm not saying in any way that that's what you're experiencing, but a lot of times I hear when I talk to people about whether what they do is inclusive. Well, we've never had blind students, or we've never had a person with this disability or that disability. And the problem is, that's true. But you know, which comes first the chicken or the egg? Do you need to have the students before you make the inclusion happen? Or do you make the inclusion happen, and then tell people so that they will come because so often, most of us just don't pay attention to or even think about trying to pay attention to things where there isn't access, because we're just working hard to deal with what we can get some inclusion and accessibility out. Oh, so the other things never really get our focus. And it has to start somewhere. And typically, from my experience, it really happens best when somebody starts the process of making sure that there is inclusion, accessiBe that I worked for, that makes products that helped make websites more inclusive and available to persons with disabilities started, because it's an Israeli company where the law said you got to make websites accessible. And the guys who started it, actually, first work for a company well started a company that made websites. And then two years after they formed the company, Israel came along and said, You got to make our websites accessible. So then they started doing it. And the the population of customers for accessiBe has grown tremendously, because people recognize the value of doing it. And it's not mostly overly expensive to do. But it really starts better there than waiting for the demand. Because it should be part of the cost of doing business.   Sylvia Bartley  42:03 Yeah, absolutely. I agree with you. And JSOC, it's a it's a special place. Typically, people contact JSOC. And they say we want to bring our students here or run the programs in the facility. And so that's typically how kind of that kind of their programming works. You know, the programs are developed based on the partnerships. It is a smaller nonprofit. And we're trying to, you know, we're currently going to go into a capital campaign, so we can raise money to have staff, there's no staff there right now, it is all done by volunteers. And so you know, we really want to build the organization to have staff, so we can do better programming, we can scale and we can do more things that makes us more inclusive. Yeah. So yes, that's a really good point.   Michael Hingson  42:52 And volunteers are the heart and souls of nonprofits, and often really do shape the mission. And then it's, some of them become staff, of course, but it's up to the volunteers and the people to really shape the mission going forward. And then that's an important thing to do. So I'm with you.   Sylvia Bartley  43:13 Absolutely.   Michael Hingson  43:15 So where where is next for you? Do you have any notion yet? Or are you just enjoying what you're doing, and you're not yet overly concerned about some sort of way to get paid for what you do?   Sylvia Bartley  43:29 Right now, you know, there's a couple of irons in the fire was leave it at that, we'll see what pans out. I'm all about path and purpose and the universe, doing its thing. So we will see what happened there. But in the meantime, I'm continuing to do what I love, which is really getting involved volunteer, and, you know, network and do my podcast to go out to have a podcast. And that gives me more time to focus on that, because I'm purely doing that by myself. And making sure I get good guests and good topics and, you know, really providing information that can help our listeners make good decisions about their lifestyle. will tell us   Michael Hingson  44:08 more about the podcast about podcasts, because obviously we're on one now. So I'd love to love to learn more.   Sylvia Bartley  44:17 You know, podcasts is a way of getting information out there to to our listeners in a different way. Right? I think people are getting very tired or the traditional media outlets and podcasts is taken off. And my podcast is called the more we know, community show. Conversations cultivating change. And really again, it's focusing on addressing the social determinants of health by primarily for the black community. And I do that through storytelling, really having great guests that are changemakers leaders, really driving change either through their story of what they do, or you know, working with a nonprofit and also talking about equity and providing infant ation around health equity and what people need to know, in order to make good decisions about their health and their lifestyle. And it's all about information. And it's data driven information as well. And my guest often nominal third is, again, changemakers in their own right, and just very inspiring. And so I use this platform to tell them stories to tell their truths, to provide information. It's also a radio show in Minnesota on camo J, a 9.9 FM every Sunday at 12, noon, central time. So I got to produce this thing on a weekly basis. So that takes a lot as well. So now that I am not working full time, I've got time to focus on that and to develop it as well. So yeah, that's what I'm doing my podcast.   Michael Hingson  45:48 Well, that's pretty cool. And you're having fun producing it and learning to be an audio editor and all those things.   Sylvia Bartley  45:54 Well, I have something for me, I'm not going to attempt to do that. But I have to find my guest. And obviously, the content, and I review the edit in and I do the little marketing for it. So it's quite a lot, as you know, and I do it on a weekly basis. After the knock it out. Sometimes I do replays, but I gotta knock it out. And so I'm looking here to get some sponsorship, hopefully, so I can hire folks to do it, to do it for me, and, you know, do a better job on my social media. I'm not very good at that. It takes a lot of time. And I don't have the time to do all of that. So   Michael Hingson  46:31 it doesn't I used to put out a newsletter on a regular basis. And, and don't anymore just because the time gets away. Time flies, and social media is a great time sponge. So it's, it's easy to spend a lot of time doing social media, and there are only so many hours in the day.   Sylvia Bartley  46:49 Exactly, exactly. And there's so many talented people out there doing social media. I can't even even if I tried, you know?   Michael Hingson  46:56 Yeah. Yeah, some of us just have different gifts. Who are some of your favorite guests for your podcast?   Sylvia Bartley  47:05 You know, I've had so many gays I started doing this in 2015 under a different brand called the black leadership redefined. And primarily based in Minnesota. And so my guess had been anybody from Senator Tina Smith to Chief of Police, Rondo, Redondo to the Attorney General Keith Ellison, to nickimja levy Armstrong, who's a civil rights activist in the Twin Cities, to all of these phenomenal African American female coaches and leaders and ministers. I've had some deep, meaningful, moving conversations with people. But I think the ones that moved me the most are those that are telling their stories that kind of break your heart. And it doesn't move, make it it breaks your heart, but it moves me because they took their pain. And they transform that to something impactful, that really impacts and change the lives of many. And typically there are people whose spouses or, or siblings or loved ones has been murdered through to sex trafficking or at the hands of the police or at the hands of, obviously criminals. And what they did with that to really start nonprofits and provide refuge and help and support for other people. Those stories really touched me the most, you know,   Michael Hingson  48:33 yeah. You have written a book, or how many books have you written? I've just written one, just one so far. So far. That's enough.   Sylvia Bartley  48:42 That one's brewing at some point.   Michael Hingson  48:45 Well, Tom, tell me about your book, if you would.   Sylvia Bartley  48:47 Yeah, my book is called turn aside. Using spirituality and my path to emotional health. And the book I wrote, really, because on my interest in science, the brain neurophysiology and spirituality, and emotional health, and recognizing that the areas in the brain that are associated with all fear, those are areas that intersect at some point, or are the same areas. So that got me and then with my experience, working in the field of Parkinson's and movement disorders, we have all these wonderful experts from around the world and what I learned in their presence and by taking seminars, I recognized that there was a intersectionality between these three, and then I took my own experience, and wondered how I can use this information for the better right to help heal myself, someone living with depression, as well as helping giving back to community. And so I, you know, start the book off by doing a part by biography so the audience could connect with me and understand where I'm coming from, but then going deep into not really deep but going into the side Science, and making that connection, and how we can use that to really help improve our lives or the lives of others. And there's a lot in there about volunteering and giving back to my community. Because when I think about my living with my depression, at the time, it was pretty bad when I wrote the book. And, you know, I even wrote in a book that I saw it as a gift, because it really does help me to go deep internally, to connect to, you know, my spiritual path to really understand why I'm suffering like this emotionally. What am I supposed to do with it? And, you know, how do I help other people, and it kept me, I was like, getting me grounded. But it really did really get me to ask those deep spiritual questions, which has really helped me to evolve as a person, spiritually, emotionally and physically. And so, you know, the book really centered around that, and how we can use that knowledge, about intersectionality will free to really help other people's lives as well. And then not to mention talking, talking about depression is something that many people do, particularly those who are very visible and in senior leadership positions. But it was important for me to do so because I want to help normalize it. I want to get to a point where we can talk about depression, and people stop saying that you're brave, and you're being vulnerable. And you're being very courageous, because it, there's a high percentage of people that have depression, and not many people want to talk about it, because of the stigma, and the shame that unfortunately, is still associated with emotional health and mental wellness. So you know, I'm doing my liberal part to help break that stigma, and to get people to talk about it. Because once you talk about it, and you acknowledge it in my situation, it was a first step towards healing. And I lived with depression, undiagnosed for most of my life, being diagnosed in 2017, when I published my book, was just very cathartic. And it was a big weight off my shoulder because I didn't have to hide it. I didn't have to battle it behind closed doors, and for the first time, I got help, and then I could address it in a very mindful, holistic way that really has helped me. And I can proudly say, today, I feel the best I've ever felt in my whole entire life, emotionally, physically, and spiritually,   Michael Hingson  52:25 is depression, more of a physical or mental and emotional thing?   Sylvia Bartley  52:31 Well, it is a physiological it can be I mean, depression comes in many forms, and it's different for everybody. But there's absolutely a physiological component to some kind of depression with as a chemical imbalance, due to some over activity under activity, or certain areas in our brain, particularly the basal ganglia, which is your kind of seed of emotion. And so, you know, that's, that's definitely one of the causes, but not many people know, what are the like real cause of people's depression, because it's different for everybody. And sometimes it could be experiential, it could be any reaction to something very traumatic. And then hopefully, those situations it doesn't kind of last long. But if it is, neurochemical, then definitely people you know, need to get professional help for that outside of talk therapy.   Michael Hingson  53:26 Right. Well, in terms in terms of spirituality, how does that enter into and when you talk about spirituality? What do you mean by that?   Sylvia Bartley  53:38 So what I mean about that is I mean, looking inwards and looking like at the wider plan, knowing that I call it the universe, right? People will say, call it God, or, and I do believe in God, and I pray to God, right talk about universal timing and the power of the universal. And knowing that there is a bigger plan, greater than us, there was a life here before us, I believe, we chose up I believe we choose our parents, I believe, we come here with an assignment, everybody comes with an assignment. And I believe that by saying that, I believe we will have our path and our purpose. And my goal is to align with my path and my purpose so I can really live to my full potential in this lifetime. And that's what I mean about spirituality. So it's less about the external factors, less about striving to externally achieved but more to internally achieved, and that achievement is alignment with my spiritual path and purpose. And I believe once I do that, and when I achieve that, everything will fall into place, and I'll be at peace, and I will kind of live my full life and I'm and again, I don't know if I'll ever be fully on my path and purpose. I'm always seeking. I call myself a seeker. I'm always seeking I'm asking a question, but I feel I'm pretty much on the on track and it feels Good. And I know when I'm off track because it doesn't feel good when I'm doing things that doesn't sit right with me. And, you know, it's not it's very difficult for me to do and it's not what I'm supposed to be doing. And so I'm aware enough now to say, well, I'm going to submit that to the universe. And I'm just going to, you know, reset and redirect myself to make sure that I am on path so I can do it on put on this earth to do and as well. Yeah.   Michael Hingson  55:27 Whether you call it the universe, or God, do you believe that God talks to us,   Sylvia Bartley  55:33 I believe God talks us in many ways. Now, you know, you're not going to hear a voice or you're not going to see a burning bush either. But you're going to have signs some people do. That's not me. But you'll have signs you will have feelings. And you will hear stuff, it's not going to be a voice again, but you will hear messages. And and that will come maybe in your dreams, maybe through another person that you're talking to. But the important thing is, one has got to be in a place to be able to hear and receive, I believe this is of   Michael Hingson  56:04 everybody. And there's the reality of   Sylvia Bartley  56:07 it still. And this is where the mindfulness and the spirituality comes into it. Being sterile. Whether you're meditating or just being still and tapping into silence, this is when you're in a best place to receive and understand what it is that your assignment and your purposes, this is, when you're in your best place to receive those messages that you're so desperately seeking that you know, and to receive that guidance. And that's a big part of spirituality, together with doing things that prepares your vessel because we are physical matter, right. And our spirits live within us, we house our spirit, and we house our soul. And, you know, I focus on trying to keep my vessel as healthy as possible. So it's in a good strong place to house my spirit, and my soul is all intertwined. You know, it's very complicated, very deep. But that is a big part of it. So we are, you know, it, we're in a flamed body, we have inflammation due to the fact that we're eating foods that are inflammatory, and we have inflamed guts, and we're having, you know, inflamed neurons in our brain, because we're in flames that got inflamed the brain to I believe, and we're having a chronic illness, it's very difficult for us to do what we're supposed to do on this earth. And so, you know, our physical being, and health is obviously very important. And it ties closely with our emotional health, as well,   Michael Hingson  57:36 I think it is possible to hear a voice. But again, I think it all comes down to exactly what you said, we get messages in many ways, because God or the universe is is always trying to talk to people. And I think we have, oftentimes, selectively and collectively chosen to ignore it, because we think we know all the answers. And if there's one thing I've learned in 72 years, we don't necessarily know the answers, but the answers are available if we look for them. And I think that's really what you're saying, which goes back to being calm, being quiet, taking time to, to analyze, we're in the process of writing a book. Finally, for the moment, called a guide dogs Guide to Being brave, which is all about learning to control fear and learning that fear does not need to be blinding as I describe it, or paralyzing or whatever you want to call it. But that it can be an absolutely helpful thing in teaching you to make decisions, but you need to learn to control it. And you need to learn to recognize its value, just like we need to learn to recognize the value of pain or anything else in our lives. And, in fact, if we do that, and we we recognize what fear can really do for us by slowing down by analyzing by internalizing, we will be much stronger for it. And we're more apt to hear that voice that oftentimes people just call that quiet voice that we may not hear.   Sylvia Bartley  59:14 Mm hmm. Absolutely agree.   Michael Hingson  59:18 So it's, it's, it is a challenge because we're not used to doing that. We don't like giving up control, if you will. Yep,   Sylvia Bartley  59:26 yep. But once you know, and everyone will get there once we, for me, once I got there is a journey doesn't happen overnight. It can take years to get to that place. But you know, once you get there, it's so enlightening. And you just feel like it's funny, there's not there's not often a feel like I might directly on path and purpose. And I get a glimpse of it once in a while. And it feels so different. It feels so light, it feels so right. And that's where I want to be for, you know, a majority of my time that I have left in his lifetime, I want to feel that by the time so that is my, that is my goal.   Michael Hingson  1:00:05 And the more you seek it, the more of it you'll find. Yeah, hopefully, you will. It's it's all a matter of realizing it's there if we look for it, and it may not show up exactly the way we expected. But so the issue is really that it shows up, right?   Sylvia Bartley  1:00:24 It is. And yeah, I read somewhere that says, you know, just be open, just really try your best show up. Because people say, How do you know your own path and purpose? How do you know this is right for me, you know, you got to show up, you got to do your best. And you got to give it all you've got, and you got to let it go. Let it go to the universe and have no expectation for the outcome. But just be open to all kinds of possibilities and where that will lead you. Very hard to do. Yeah. And it's   Michael Hingson  1:00:53 always appropriate to ask the question, Did I do my best? Did I did I get the message? Am I missing something? And look for the answer? Yes, Sylvia, this has been a lot of fun. We have spent an hour and we didn't even have a snowball fight Darn. too hot for that. It's it's gonna be over 90. We're cooling down out here right now. We were over 100 for the last 10 days. So it's hot here in California. But I really enjoyed having you. How can people reach out to you or learn more about you?   Sylvia Bartley  1:01:30 Excellent. Thank you for asking that question. I think if you go to my website, I have a little website here. And it's sylvia-bartley.com. That is S Y L V I A hyphen, B A R T L E Y.com. And you can you know, just tell you a bit more about me. You can see my podcasts, my books, and there's a method of getting in touch with me if you want to.   Michael Hingson  1:01:57 Is the podcast available in a variety of different places? Or is the best website?   Sylvia Bartley  1:02:04 It's available on multiple platforms? Apple, Google, Spotify. And what's the community show with Dr. Sylvia? Conversations cultivating change? Do the   Michael Hingson  1:02:17 first part again. The more we know Community, the more we know. Okay.   Sylvia Bartley  1:02:22 Community show with Dr. Sylvia. Conversations cultivating change.   Michael Hingson  1:02:28 And I hope that people will seek you out. This has been for me very fascinating. I love learning new things and getting a chance to meet fascinating people. And I'll buy into the fact that you're a unicorn, it works for me.   Sylvia Bartley  1:02:46 Well, I'm just me, you know, but I appreciate the invite to be on your podcast, Michael. And thank you very much for providing this platform to share stories and information with your listeners too.   Michael Hingson  1:02:59 Thank you and we love stories and if people would love to comment, I really appreciate it if you would. I'd love to hear from you about this. You can reach out to me at Mic

In this episode, host Aaron Lohr looks back at the Endocrine Society’s Type 1 Diabetes Fellows Conference, which occurred last year, with two conference presenters talking about developmental challenges in type 1 diabetes, including psychological and social, across the lifespan. Our guests are Linda Siminerio, PhD, professor of medicine at University of Pittsburgh and executive director of the university’s Diabetes Institute, and Jill Weissberg-Benchell, PhD, professor of psychiatry and behavioral sciences at Northwestern University. Dr. Siminerio’s presentation was titled, “Identifying and Confronting Challenging Transitions.” Dr. Weissberg-Benchell’s presentation was titled, “Developmental Perspectives in the Psychosocial Aspects of Diabetes.” Thanks to the conference’s supporters who have made this episode possible through unrestricted, educational grants: Abbott Laboratories, Dexcom, Insulet, Lilly, Medtronic, Novo Nordisk, PreventionBio, and Tandem Diabetes Care. Editor’s note: this interview was recorded in 2022. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

Headache medicine specialist Rebecca C. Burch, MD, joins us to talk about triptan use in patients with cardiovascular risk factors.Listen in as they clear up confusion about which patients should avoid triptans due to cardiovascular concerns.You'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Anthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson UniversitySteven E. Nissen, MD, MACC, the Chief Academic Officer at the Heart and Vascular Institute and the Lewis and Patricia Dickey Chair in Cardiovascular Medicine Professor of Medicine at the Cleveland Clinic Lerner School of Medicine at Case Western Reserve UniversityJoseph Scherger, MD, MPH, Family Physician, Primary Care 365, Eisenhower HealthCraig D. Williams, PharmD, FNLA, BCPS, Clinical Professor, Department of Pharmacy Practice at the Oregon Health and Science UniversityFor the purposes of disclosure, Dr. Steven Nissen reports a relevant financial relationship with AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Esperion, Medtronic, Novartis, Pfizer, Silence Therapeutics (grants/research support). The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.Pharmacist's Letter offers CE credit for this podcast. Log in to your Pharmacist's Letter account and look for the title of this podcast in the list of available CE courses.If you're not yet a Pharmacist's Letter subscriber, find out more about our product offerings at trchealthcare.com. Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com. 

Susan Weinschenk has a Ph.D. in Psychology and is the Chief Behavioral Scientist, and CEO at The Team W, Inc. Susan consults with Fortune 1000 companies, start-ups, governments, and non-profits, and is the author of several books, including 100 Things Every Designer Needs To Know About People, 100 MORE Things Every Designer Needs To Know About People and How To Get People To Do Stuff. Dr. Weinschenk's area of expertise is the brain and behavioral science applied to the design of products and services. Her clients include Medtronic, Disney, the Mayo Clinic, Zappos, the European Union, Discover Financial, and United Health Care. Susan is co-host of the HumanTech podcast and writes her blog and a column for Psychology Today online. In this episode, Susan shared great insights on the Brain and Creativity and how we could train our brains to produce the best creative solutions. What are different frameworks to rewire our brain to for creativity? We then spoke on the role of perception in enhancing the brain. And how designers can use the same to improve the user experience. We concluded the show with resources and frameworks on behavioral sciences. Takeaways - Building creating, the role of perception in enhancing the brain, Methods to improve creativity. Books by Susan Weinschenk Thank you for listening to this episode of Nodes of Design. We hope you enjoy the Nodes of Design Podcast on your favorite podcast platforms- Apple Podcast, Spotify, Google Podcasts, Amazon Music, and many more. If this episode helped you understand and learn something new, please share and be a part of the knowledge-sharing community #Spreadknowledge. This podcast aims to make design education accessible to all. Nodes of Design is a non-profit and self-sponsored initiative by Tejj.

My guest is John M. Climaco.  John M. Climaco, JD is the Chairman and CEO of CNS Pharmaceuticals, Inc., (NASDAQ: CNSP) a company Mr. Climaco took public in 2019. CNS is engaged in the research and development of new treatments for malignancies of the brain and central nervous system. The Company's lead candidate is Berubicin, an anthracycline developed at the prestigious University of Texas MD Anderson Cancer Center, the largest cancer research and treatment center in the world. A seasoned entrepreneur, executive, attorney and director, Mr. Climaco has a distinctive record of business successes and more than 19 years of experience managing the operations, strategies and finances of public and private companies.  As President & CEO of Axial Biotech for over a decade, Mr. Climaco was instrumental in bringing genomic medicine to orthopaedics. Under Mr. Climaco's leadership, Axial developed and commercialized ScoliScore, a genetic test designed to determine scoliosis prognosis. The Chicago Tribune called ScoliScore “a crystal ball for the spine” and Orthopaedics This Week recognized ScoliScore as the Best New Diagnostics Technology for Spine Care 2010. Leading Axial from inception through to international commercialization, Mr. Climaco raised over $50MM in venture capital, created partnerships with Medtronic, Johnson & Johnson and Smith & Nephew and grew the company's annual revenue to over $6MM by its second year of commercial operations. A current or former director of several public companies including Moleculin Biotech (NASDAQ: MBRX), Digirad Corporation (NASDAQ: DRAD), PDI, Inc. (NASDAQ: PDII), PermaFix Environmental Solutions, Inc. (NASDAQ: PESI) and InfuSystem Holdings, Inc. (NASDAQ: INFU), Mr. Climaco has taken a leadership role in complex and difficult turn around efforts. As Chairman of the Strategic Advisory Committees of DRAD and PESI, Mr. Climaco advised management teams on M&A opportunities, restructurings, asset divestments, equity financings and strategic partnerships. Social: Linkedin: https://www.linkedin.com/in/john-climaco-62477a1/ For more episodes and information, visit us at https://www.digitalnicheagency.com/media Apple Podcasts: https://podcasts.apple.com/us/podcast... Spotify: https://open.spotify.com/show/4zS5V79... Stitcher: https://www.stitcher.com/s?fid=524781... Follow Digital Niche Agency on Socials for Up To Date Marketing Expertise and Insights Facebook: https://www.facebook.com/digitalniche... Linkedin: https://www.linkedin.com/company/digi... Instagram: DNA - Digital Niche Agency (@digitalnicheagency) • Instagram photos and videos. Twitter: https://twitter.com/DNAgency_CA YouTube: https://www.youtube.com/channel/UCDlz… #marketingtips #advice #marketingquotes #socialmediagency #marketingagency #startup #marketingtools  #socialmediaexperts #marketingguru #digitalmarketers #searchengineoptimization #entrepreneurship #smallbusiness #crowdfunding #marketing #strategies #websitetraffic #instagramads #socialmediamarketing #content101 #contentcreation #businesspodcasts #JasonFishman, #ShariNoonan  #mentorpodcast #educationalpodcast

➡️ Like The Podcast? Leave A Rating: https://ratethispodcast.com/successstory   ➡️ About The Guest⁣ John M. Climaco, JD is the Chairman and CEO of CNS Pharmaceuticals, Inc., (NASDAQ: CNSP) a company Mr. Climaco took public in 2019. CNS is engaged in the research and development of new treatments for malignancies of the brain and central nervous system. The Company's lead candidate is Berubicin, an anthracycline developed at the prestigious University of Texas MD Anderson Cancer Center, the largest cancer research and treatment center in the world. A seasoned entrepreneur, executive, attorney, and director, Mr. Climaco has a remarkable record of business successes and more than 19 years of experience managing the operations, strategies, and finances of public and private companies.  As President & CEO of Axial Biotech for over a decade, Mr. Climaco was instrumental in bringing genomic medicine to orthopedics. Under Mr. Climaco's leadership, Axial developed and commercialized ScoliScore, a genetic test designed to determine scoliosis prognosis. The Chicago Tribune called ScoliScore “a crystal ball for the spine” and Orthopaedics This Week recognized ScoliScore as the Best New Diagnostics Technology for Spine Care 2010. Leading Axial from inception to international commercialization, Mr. Climaco raised over $50MM in venture capital, created partnerships with Medtronic, Johnson & Johnson, and Smith & Nephew, and grew the company's annual revenue to over $6MM by its second year of commercial operations. A current or former director of several public companies including Moleculin Biotech (NASDAQ: MBRX), Digirad Corporation (NASDAQ: DRAD), PDI, Inc. (NASDAQ: PDII), PermaFix Environmental Solutions, Inc. (NASDAQ: PESI) and InfuSystem Holdings, Inc. (NASDAQ: INFU), Mr. Climaco has taken a leadership role in complex and difficult turn around efforts. As Chairman of the Strategic Advisory Committees of DRAD and PESI, Mr. Climaco advised management teams on M&A opportunities, restructurings, asset divestments, equity financings, and strategic partnerships. ➡️ Show Links https://www.instagram.com/jclimaco/       https://twitter.com/cns_pharma/  https://www.linkedin.com/in/john-climaco-62477a1/      ➡️ Podcast Sponsors HUBSPOT - https://hubspot.sjv.io/successstorypod ➡️ Talking Points⁣ 00:00 - Intro 03:05 - John Climaco's origin story 07:35 - Was there a de facto treatment at all before John's company? 12:20 - Is this treatment something that can transcend cancer? 19:33 - How is the business around such drugs accessible to everyone in the market? 28:46 - Why is the metastatic market growing? 30:18 - What are the steps to make this a de facto treatment? 35:52 - Balancing the pricing strategies when going into the market with a life-saving drug 40:06 - What does John Climaco want his legacy to be? 42:58 - Where can people connect with John Climaco? 43:33 - The biggest challenge John Climaco has overcome in his professional life 46:35 - The most impactful person in John Climaco's life 49:43 - John Climaco's book or podcast recommendation 51:43 - What would John Climaco tell his 20-year-old self? 52:09 - What does success mean to John Climaco? Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this episode, your diligent team of DeviceTalkers - Executive Editor Chris Newmarker, Pharma Editor Brian Buntz, Managing Editor Jim Hammerand, Senior Editor Danielle Kirsh, Associate Editor Sean Whooley and DeviceTalks Editorial Director Tom Salemi – assembled to review our Top 10 events, trends and newsmakers. We've got some highs – robots, diabetes – and some lows – Supply Chain, CPAP machines – and a whole lot of interesting things right in between. All an all, we're bullish on what's to come in 2023! And we only mentioned Covid-19 once. Companies mention include Abbott, Abiomed, Ambu, Becton Dickinson, Boston Scientific, CMR Surgical, Dexcom, Endiatx, embecta, Intuitive, Johnson & Johnson Medtech, Medtronic, Neuralink, Philips, Senseonics, Stryker, Synchron, Vicarious Surgical, Zimmer Biomet, ZimVie, and many more. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to this podcast on any major podcast player.

Welcome to the What's Next! podcast with Tiffani Bova.    In the search for life's purpose, Bill George has an authentic perspective. His brilliant insight hones in on the characteristics needed to shape the next generation of leaders, inspiring others through courage, empathy, and vision for the future. In his latest remastering of the subject, The Emerging Leaders Edition of North, Bill explores the topic of leadership with top executives of the business world with honest conversation about their fears, failures, and ultimately how they overcame those hardships and emerged successful.   Bill George is the former chairman and chief executive officer of Medtronic.  He joined Medtronic in 1989 as president and chief operating officer, was chief executive officer from 1991-2001, and board chair from 1996-2002. He is currently a senior fellow at Harvard Business School, where he has taught leadership since 2004.     Bill is the author of: Discover Your True North and The Discover Your True North Field book, Authentic Leadership, 7 Lessons for Leading in Crisis True North, Finding Your True North, and True North Groups. He served on the boards of Goldman Sachs, ExxonMobil, Novartis, Target, and Mayo Clinic. He received his BSIE with high honors from Georgia Tech, his MBA with high distinction from Harvard University, where he was a Baker Scholar, and honorary PhDs from Georgia Tech, Mayo Medical School, University of St. Thomas, Augsburg College and Bryant University.        THIS EPISODE IS PERFECT FOR…  emerging leaders and seasoned professionals alike who wish to find their purpose and lead with their hearts full of passion and courage.    TODAY'S MAIN MESSAGE… the real magic happens when business leaders, employees, and customers alike can align their values with the values of the business. This creates genuine value for the company and inspires the public view of your brand.      WHAT  I  LOVE  MOST… Bill has a practical approach to leadership that involves empathy from the bottom up. In his view, the only way to be a successful leader is understanding the needs of workers across all levels of the business spectrum to create a sense of belonging and inclusion.     Running time: 30:36 Subscribe on iTunes      Find Tiffani on social:  Facebook  Twitter LinkedIn Instagram   Find Bill on social: Website Facebook Twitter LinkedIn   Brian's Book: True North Emerging Leader Edition

In der heutigen Folge „Alles auf Aktien“ sprechen die Finanzjournalisten Daniel Eckert und Holger Zschäpitz über eine Zinsbombe aus dem Fernen Osten, bombastische Zahlen bei Nike und die Bionik-Chance des Jahrhunderts. Außerdem geht es um Deutsche Bank, Munich Re, Allianz, Commerzbank, Vonovia, Aroundtown, LEG Immobilien, Nippon Sanso, Itochu, Rohm, Fanuc, JVCKennwood, Tamura Corp, Monega Innovation Fonds (WKN: 532102), MSCI Japan (WKN: LYX0YC), iShares MSCI Japan Small Cap (WKN: A0Q1YX), Vaneck Bionic Engineering (IE0005TF96I9) Dexcom, Stryker, Medtronic, Zimmer Biomet Holdings, Sonova, Straumann, Edwards Lifescience, Insulet, Inspire Medical Systems und Smith & Nephew. Wir freuen uns an Feedback über aaa@welt.de. Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

“If the average person just more consistently did what they already know they'd be healthier, happier, and be making more money.” – Brian Moran Brian Moran the New York Times bestselling author of “The 12 Week Year: Get More Done in 12 Weeks than Others Do in 12 Months” is going to share how to get more done in less time. He will take us into this execution system he developed while also sharing easy to implement time management strategies. He also connects the dots back to why it is important to create our life vision so we can structure our time and goals around that vision. You will learn tactical steps that you can use today to move closer to the life you desire. Loved this conversation so much! Tune in now and you can access the show notes at thegoodlifecoach.com/223. Are you enjoying the podcast? If so, I would love your review on Apple Podcasts. It only takes a minute. 1. Click on this link 2. Click “View in iTunes” button 3. Click “Subscribe” button 4. Click “Ratings and Reviews” text 5. Click to rate and leave short review and you're done! Thank you for listening to the show! WHAT YOU'LL LEARN: 1. Why the 12 week year is an execution system and how that helps you get more done in less time. 2. It's not enough to know. You have to execute. Knowledge is only powerful if you act on it. 3. Get out of the annual environment. With this program, you are going to stop after 12 weeks and that is your year. Measure your success or failure and measure the progress and then go again. It's a fluid process. You can use this professionally or personally. You can do anything for 12 weeks and then decide is that somethingI want to do again. 4. Your vision is you're why. Your goals NEED to align with the vision. 5. At the goal level, know the difference between goals and tactics and outcomes and actions. The actions we have control over. Goals are outcomes. 6. Make sure at the goal level that is measurable – it's an outcome. 7. Determine what are the most important actions. Most plans are conceptual not tactical. You need to spell out the specific actions and focus on “less is more”. 8. Stay connected to your vision by putting the longer term vision in front of you – laminate a card you can look at every day. Create visual reminders. 9. The difference between a habit and routine is key. Ex, going to the gym is a routine not a habit and routines are what drive success. How you begin and end your day needs a routine. The key is to start off positive. End your day with gratitude. 10. How to manage time. Time blocking – 3 core blocks: A. Strategic Block -3 hours blocked during the week. No interruptions – working on the business not in the business. THIS CAN CHANGE YOUR LIFE. B. Buffer Blocks – these are designed to deal with the emails/low level stuff. Ex, I return calls between 4-5pm. Don't check your emails when they come in. Block time in to address it. C. Break out blocks – schedule time away from work to do something just for you to recharge. The Four Disciplines of the 12 Week Year Vision – You have to know what you want. Planning – You have to ask – “What matters most?” Execution – Then ask, “Am I doing it?” Measurement – “Is it producing?” RESOURCES MENTIONED Brian's Book: The 12 Week Year: Get More Done in 12 Weeks than Others Do in 12 Months Brian's website – https://12weekyear.com/ – Michele on Instagram ABOUT TODAY'S GUEST: Brian Moran, President and Founder of The 12 Week Year, has thirty plus years of expertise as a corporate executive, entrepreneur, consultant and coach. Brian is a recognized expert in the field of leadership and execution. His realization that most people don't lack ideas, but struggle with effective implementation led him to the development of ‘The 12 Week Year'. His client list includes industry leaders like Allstate, Aon, Becton Dickinson, Dunkin' Brands, Keller Williams, Mass Mutual, Medtronic, Merrill Lynch, Meritage Homes, Nationwide, New York Life, Papa Johns Pizza, Prudential State Farm and Taylor Made just to name a few. Brian resides in Michigan with his wife Judy and two daughters. Thank you for listening to the show!

The learnings in this episode that can transform YOUR life, YOUR work, YOUR sense of value and purpose, YOUR self- and team-leadership, regardless of where you work, what job or charity you serve, whether or not you are an entrepreneur... It can change YOUR life for the good!

In this episode, we'll speak with ReCor Medical's CEO Andy Weiss and Helen Reeve-Stoffer, PHD, the company's vice president of clinical affairs. The pair joined the renal denervation company in 2013, before disappointing results of a Medtronic-trial temporarily cratered the entire space. But now through careful clinical testing ReCor Medical is climbing out of that hole and demonstrating the technology could be an effective tool against serious hypertension. To hear the interview we conducted with Andy Weiss in 2021, go here. Executive Editor Chris Newmarker and Tom Salemi, editorial director of DeviceTalks, begin making plans for next week's end-of-year coverage. If you want to contribute your insights go here and record your own message for the podcast. https://www.massdevice.com/devicetalks-weekly-whats-your-top-story-of-2022/ Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on any podcast application.

Dan Volz, president of the neurovascular business at Medtronic, lays out the dire facts regarding stroke. Less than 10 percent of the 15 million strokes that occur each year worldwide are treated, and the number of strokes grows by 10% each year. In this episode, we'll explore Medtronic's new agreement with Avail Medsystems, which sells access to a network of communication devices that provide audio and video connection to operating rooms. Avail CEO Daniel Hawkins joins in on the conversation explaining how Avail can facilitation collaboration between surgeons, speed training on new life-saving devices, and even help engineers observe procedures so they can develop new critical tools. The pair will discuss how Medtronic is using Avail's products day-to-day as well as part of the company's new Co-Lab Platform to help those developing new neurovascular products outside of Medtronic. Thank you to Cretex Medical for sponsoring this episode. Thank you for listening to the MedtronicTalks Podcast. You can subscribe to this podcast on any major podcast player.

ABOUT BILL GEORGE Bill George is a celebrated leader who served as Chair and CEO of Medtronic, the world's leading medical technology company. He is an executive fellow at Harvard Business School, where he has taught leadership since 2004, and is the bestselling author of many books, including Discover Your True North. Bill also served as a director at Goldman Sachs, ExxonMobil, Novartis, Target, the Mayo Clinic, and World Economic Forum USA. In this episode of the Elevate Podcast, Bill joins host Robert Glazer to discuss his leadership career, the importance of purpose-driven leadership, and the challenges Mark Zuckerberg is facing with Meta. Show Notes  

Medtronic's Pat McDonnell has been working with Deep Brain Stimulation technology for over 20 years. In this episode Pat offers his thoughts on DBS and gives us his perspective on being an exhibitor at the Parkinson's Association of San Diego's Empowerment Day.For more information on DBS from Medtronic, click here.http://www.medtronic.com/DBSFor more information about how the Parkinson's Association of San Diego can help you, click here.

In this episode, Celine Martin, company group chairman, Cardiovascular & Specialty Solutions Group, offers insights from her career at Johnson & Johnson. What are the four variables you need to consider to thrive in a global company. Martin also shares insights on cardiac ablation, neurovascular, and where the company is headed following the acquisition of Abiomed. Paul Grand, CEO of Medtech Innovator, joins as a co-host offering insights on Chris Newmarker's Newsmakers – Moon Surgical, Butterfly Network, Medtronic, Avail Medsystems, Dexcom, and Fresenius Medical. Grand shares a personal connection to one of the companies. Grand, Newmarker and Tom Salemi also share their thoughts on the retirement of Mike Mussallem, CEO of Edwards Lifesciences. Thank you to Nordson Medical for sponsoring this episode. Go to NordsonMedical.com for more information. Thank you for listening to the DeviceTalks Weekly Podcast You can subscribe to this podcast on any major podcast player.

Drs. Tina McKay and Zhongcong Xie discuss delirium biomarkers with Dr. Adam Striker. Learn about the latest research, the practical implications for patient safety, the connection between delirium biomarkers and Alzheimer's disease, and more. Recorded November 2022.  This podcast episode was developed in collaboration with the Committee on Geriatric Anesthesia and funded by ASA's Industry Supporters. Thank you to our Industry supporters for their year-round support of ASA: Baudax Bio, Edwards Lifesciences, Fresenius Kabi, GE Healthcare, Heron Therapeutics, Masimo, Medtronic, and Merck. 

Welcome to an episode with Bill George, former chairman and CEO of Medtronic and currently a professor at Harvard Business School. He has written two of the most enduring leadership classics of all time: Authentic Leadership and True North. Now, Bill has written a new book aimed at the next generation of leaders, the Emerging Leaders Edition of True North, coauthored with millennial entrepreneur Zach Clayton. Get Bill's new book here. This book is a clarion call to emerging leaders to step up to lead their organizations with their hearts, not just their heads, as authentic leaders who lead with purpose by inspiring and coaching their teammates. It heralds the end of the baby boomer era of Jack Welch, when too many leaders focused on maximizing shareholder value and taking shortcuts rather than building sustainable enterprises to serve all of their stakeholders. Our best hope for a better world is to empower the next generation of emerging leaders – not just those on top – to follow their True North to make this world better for everyone. The stories in this book, which came from 220 interviews with exceptional leaders, illustrate that most authentic leaders first discovered their True North through their life stories and crucibles, developed self-awareness, and then found their North Star – the purpose of their leadership. Wisdom learned from leaders like Satya Nadella, Mary Barra, Ken Frazier, Indra Nooyi, Ursula Burns, and Hubert Joly will guide emerging leaders at all levels in their development. Bill joined Medtronic in 1989 as president and chief operating officer, was chief executive officer from 1991-2001, and board chair from 1996-2002. He is currently a senior fellow at Harvard Business School, where he has taught leadership since 2004. He is the author of Discover Your True North and The Discover Your True North Field Book, Authentic Leadership, Seven Lessons for Leading in Crisis, Finding Your True North, and True North Groups. He has served on the boards of Goldman Sachs, ExxonMobil, Novartis, Target, and Mayo Clinic.  He received his BSIE with high honors from Georgia Tech, his MBA with high distinction from Harvard University, where he was a Baker Scholar, and honorary PhDs from Georgia Tech, Mayo Medical School, University of St. Thomas, Augsburg College, and Bryant University.  True North: Leading Authentically in Today's Workplace, Emerging Leader Edition. Bill George & Zach Clayton. Enjoying our podcast? Get access to sample advanced training episodes here: www.firmsconsulting.com/promo

Unfortunately, we missed Diabetes Awareness Month by a few days, but we get great insights on this dreaded disease from two players in the space. Krista Sugerman, vice President, global marketing & communications at Medtronic's diabetes business, shares how diabetes has impacted people close to her and why the company is keeping focused on how a diabetes diagnosis can take over someone's life. We also touch base with newcomer Bigfoot Biomedical. Matt Clemente, Senior Vice President of Product, Development & Delivery at Bigfoot Biomedical, shares his familial connection with diabetes and how he's dedicated his career to helping people manage the disease. Chris Newmarker also delivers his Newsmakers – Elon Musk, GE Healthcare, Boston Scientific, Apollo Endosurgery, Tital Medical, CMR Surgical, and Johnson & Johnson Medtech. Go here to hear the interview with CMR CEO Per Vegard Nerseth https://www.devicetalks.com/hear-from-the-ceos-of-two-surgical-robotics-companies-that-together-just-raised-over-1-billion/

Special guest Carolyn J. Crandall, MD, MS, MACP, Professor of Medicine at the University of California, Los Angeles School of Medicine joins us to talk about hormone therapy for menopausal symptoms.Listen in as they clarify when and how to use hormone therapy to manage menopausal symptoms.You'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Reid B. Blackwelder, MD, FAAFP, Associate Dean of Graduate and Continuing Medical Education at East Tennessee State UniversityAndrea Darby Stewart, MD, Associate Director, Family Medicine Residency at Honor Health Steven E. Nissen, MD, MACC, the Chief Academic Officer at the Heart and Vascular Institute and the Lewis and Patricia Dickey Chair in Cardiovascular Medicine Professor of Medicine at the Cleveland Clinic Lerner School of Medicine at Case Western Reserve UniversityFor the purposes of disclosure, Dr. Steven Nissen reports a relevant financial relationship with AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Esperion, Medtronic, Novartis, Pfizer, Silence Therapeutics (grants/research support). The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.Pharmacist's Letter offers CE credit for this podcast. Log in to your Pharmacist's Letter account and look for the title of this podcast in the list of available CE courses.If you're not yet a Pharmacist's Letter subscriber, find out more about our product offerings at trchealthcare.com. Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com. 

We have Don Colliver with us today. Don teaches popular public speaking courses internally at Google and around the world and speaks professionally for Fortune 500 companies including Adobe, Cisco, and Medtronic. He has performed with the Blue Man Group, toured internationally as a theatrical Google clown for contemporary circus Spiegel World, and is listed in the Cirque du Soleil performer database. In this episode, Don discusses how graphic design can be taken into account when creating engaging corporate events. He shares four ways that graphic designers can engage their audiences: by acknowledging something the audience is doing; breaking the fourth wall; providing helpful information; and reaching milestones on platforms such as Apple podcasts or Spotify. Tune in to this episode and learn about the art and impact of public speaking! Highlights: (01:28) What it's like performing with the Blue Man Group (03:35) ​​ What public speaking courses are Googlers taking? (04:50) How has Don's clown experience impacted his approach to public speaking more specifically? (07:04) What things is Don looking for before choosing to do a course? (08:45) Why is transformational public speaking impactful? (16:38) How do people get into public speaking classes? (19:45) How can trade show marketers or internal corporate marketing departments find superstar tradeshow speakers? (21:43) What are some ways that people within the same booth space can encourage audience engagement? (24:06) Don's experience in a book reading at the NewNow Creative Event and Community Center California Links: Connect with Don: Don's Book: Wink: Transforming Public Speaking with Clown Presence: Colliver, Don: 9798986276731: Amazon.com: Books Website: doncolliver.com LinkedIn: Don Colliver - Instructional Designer and Facilitator - GoogleArts | LinkedIn Twitter: Don Colliver (@doncolliver) / Twitter Connect with Yanique: Podcast www.facebook.com/groups/eventist365/ https://twitter.com/eventist365 https://www.instagram.com/eventist365/ Host https://www.facebook.com/MissYaniDoesStuff/ https://twitter.com/YaniDoesStuff https://www.instagram.com/YaniDoesStuff/ https://www.linkedin.com/in/ydacosta/ Graphic Design Firm for Corporate Events: https://www.facebook.com/TheYKMD https://twitter.com/theYKMD https://instagram.com/theYKMD https://www.linkedin.com/company/ykmd/z Graphic Design Firm Websites: Books mentioned: How to Tell a Story: The Essential Guide to Memorable Storytelling from The Moth

In this episode, Krista Sugerman, vice President, global marketing & communications at Medtronic's diabetes business, shares how diabetes has impacted people close to her and why the company is keeping focused on how a diabetes diagnosis can take over someone's life. The company is developing tools to help patients monitor their disease and developing longer-lasting equipment that could make managing the disease less of a burden for people with diabetes. This episode is sponsored by BMP Medical. Thanks for listening to the MedtronicTalks podcast. You can subscribe to this podcast on any major podcast player.

Cardiac device techs are in hot demand, but gaps in staffing and education are causing difficulties for this role. On MedAxiom HeartTalk, host Melanie Lawson talks with Kelli Shifflett, MHA, FACMPE, AVP of Revenue Growth and Business Development, HCA Physician Services, Sirena Bridges, MSPH, MSN, FNP-BC, CCDS, Clinical Director, Melissa Hauck Center for Device Therapy at Centennial Heart, and Nicole Knight, LPN, CPC, CCS-P, SVP of Revenue Cycle Solutions and Care Transformation, Medaxiom. Together, they discuss innovative strategies that your organization can use to help address this growing issue. Guest BiosKelli Shifflett, MHA, FACMPE, AVP of Revenue Growth and Business Development, HCA Physician Services – Kelli has been with HCA Physician Services for 20 years in a variety of practice operation roles from Practice Manager to Division Vice President. She resides in Austin with her family and is passionate about process improvement and finding practice efficiencies in a constantly changing healthcare environment. She enjoys her current role of partnering with companies whose products improve the daily workflows and needs patients, providers and healthcare teams. Sirena Bridges, MSPH, MSN, FNP-BC, CCDS, Clinical Director, Melissa Hauck Center for Device Therapy at Centennial Heart – Sirena has worked in the healthcare field for over 20 years; with the last 10 years working as a Nurse Practitioner in Cardiac Electrophysiology with a focus on device management of Cardiac implantable electronic devices at Centennial Heart. She became the inaugural Clinical Director of the Melissa Hauck Center for Device Therapy at Centennial Heart in Nashville in November 2021. In her role as the Clinical Director, she brings a wealth of clinical and technical expertise on interpretations, programming and troubleshooting of cardiac implantable electronic devices and remote transmissions. She also serves as a clinical resource for patients, peers and colleagues. Sirena has a Bachelor's Degree in Cardio-respiratory Care Sciences from Tennessee State University and a Master's Degree in Public Health from Meharry Medical College in addition to a Master's Degree in Nursing from Vanderbilt University. She is also a Certified Cardiac Device Specialist (CCDS) through the IBHRE (International Board of Heart Rhythm Examiners). Nicole Knight, LPN, CPC, CCS-P, EVP of Revenue Cycle Solutions and Care Transformation, Medaxiom - Nicole's decades of healthcare experience include cardiovascular and neurology practice operations, clinical management, business office management and consulting. The most recent years have been devoted to cardiovascular consulting in operations, LEAN process improvement and the revenue cycle. Prior to joining MedAxiom, Nicole served as Practice Administrator for Baptist Neurology and Northeast Florida Cardiology and Director of Operations for Jacksonville Heart Center and Louisiana Cardiology Associates. She has extensive expertise in coding, compliance and education for various specialties including cardiology, neurology, radiology, hematology/oncology, orthopedic, ENT, gastroenterology and internal medicine. Nicole has provided physician and staff coding and compliance education sessions nationally. Nicole has completed numerous education hours towards a B.S. in Health Care Administration. In addition, she maintains her LPN licensure in Louisiana and Florida. She is a member of the American Academy of Professional Coders and the American Health Information Management Association. She received her Advanced Cardiovascular Coding Certification with the Board of Medical Specialty Coding and completed the AAPC inpatient coding and reimbursement course. Nicole is a certified AHIMA ICD-10-CM Trainer and completed a LEAN Healthcare training course at Johns Hopkins University. She also serves on the Physician Practice Council for AHIMA. This episode is supported by an independent educational grant from Medtronic.

Gerry Duffy is one of Ireland's foremost keynote speakers focusing on optimizing performance both personally and professionally with global companies like Google, Facebook, Medtronic, Coca Cola, and more. Prior to speaking, Gerry took on several endurance feats including 32 marathons in 32 days as well as 10 Ironman Triathlons in 10 days. Gerry has published three books including his best seller titled Tick, Tock, Ten: A compelling blood, sweat, and tears account of competing in one of the toughest sporting endurance challenges in the world.Topics-The significance of 32 marathons in 32 days-Respect the goal and the timeline-Commitment is staying true to what you said you would do long after the mood you said it in has left-Getting clear on your “Why”-The power in having perspective-4 Keys to Success-Do simple things to an outstanding standard-“Work on yourself more than you do your work.”If you found value in this episode please be sure to leave a rating, review, and share it on your social media platform. Your 5-star feedbacks helps the show grow and helps to bring on more incredible guests like Gerry.

719: Bill George, former CEO of Medtronic and bestselling author, discusses his latest book True North: Leading Authentically in Today's Workplace and why authentic leadership is crucial for success. Bill reflects on his upbringing, his time at Honeywell, and why he felt that joining Medtronic was the perfect move for him. He then talks about insights from his book including the importance of building strong relationships based on trust as a leader, why EQ is as important if not more than IQ, and the COACH framework he developed on organizing people. Bill then talks about the men's group he has been a part of, how it helped orient and support him through his life, and why everyone should find an equally supportive group. Finally, Bill looks ahead at the future of hybrid work, gives advice for young leaders as we face major econo

You are so much more powerful than you know. yes, you have probably heard that a million times from motivational speakers and/ or coaches AND it's true. Listen as Karen Davis opens your eyes to the bigger life that you are really living once you solidify your ‘foundation and see the screen.' What if you opened yourself to possibilities that are by allowing them to be? It is very important to have a strong foundation otherwise you will deny yourself growth. It's time to create new possibilities, create new relationships, and create deep listening.About the Guest:Karen Davis, Executive Coach, Author & Speaker After 25 years in leadership roles in the business-to-business technology and services space, Karen changed her life by serving and guiding the transformation of others. She became a Professionally Certified Coach (PCC) through the International Coaching Federation. She's been coaching, consulting and facilitating leadership workshops for organizations such as Pfizer, Cisco Systems, Hewlett Packard, Medtronic as well as many other small businesses since 2008. Today, her practice focuses on one-on-one deep coaching with high-performing executives, entrepreneurs, and executive coaches who are committed to their success, ready to uncover their hidden potential and make their own unique difference in the world. Karen is the co-author of three books, How to Get the Most Out of Coaching, A Client's Guide for Optimizing the Coaching Experience, When All Boat Rise: 12 Coaches on Service as the Heart of a Thriving Practice, and Unconventional Wisdom: Stories Beyond the Mind to Awaken the Heart. Karen loves to travel, study people and learn about other cultures. You will often find her coaching with her clients at her studio near Boulder, CO or on a walk out in nature. Best of all, Karen has two fascinating adult children, Dustin and Alexa, a wonderful life partner, Alex Mill and an office dog, Jax—all of whom serve as her inspiration each and every day! Direct/Cell: 303.588.8935 Email: Karen@KarenDavisCoaching.com Website: www.KarenDavisCoaching.com Social Media Links: https://www.facebook.com/davis.karen https://www.linkedin.com/in/karendaviscoaching/ https://twitter.com/KarenDavisCoach About the Host:Cordelia Gaffar is the Ultimate Joy Monger. That means that she holds space for you to reveal your joy within. Joy Mongering is a word she created from several life experiences and based on her philosophy that self-nurturing is freedom. In fact she has created a process she calls Replenish Me ™ to help you transmute fear, rage and anger into Joy. In one of her eight books, Detached Love: Transforming Your Heart Do That You Transform Your Mind, she breaks down the Replenish Me ™ process through her research, client stories and her personal vulnerable shares. She is also the host of three host podcasts. She won Best Podcast Host for her solo show called Free to Be Show and collaborates as a co-host on Unlearning Labels and the Ultimate Coach Podcast. The multidimensional genius she is, is further demonstrated as the mother of six children whom I homeschooled for 17 years. In summary, she has won multiple awards: Best Podcast Host of 2019, Top National Influencer, Sexy Brilliant Leader, and inducted into the Global Library of Female Authors in 2020; and in 2021 nominated for Author of the Year and Health and Wellness Coach of the Year and in 2022...

This is a special episode on risk management. It is important to understand what dictates the work we do as clinical research professionals and how our work fits into the bigger picture of medical product development. This episode serves exactly that purpose. You'll be introduced to ISO 14971 Application of risk management to medical devices and learn about its relationship to ISO 14155 Clinical investigation of medical devices for human subjects — Good clinical practice. You'll also understand key terminology around risks, how to define risk, what's special about clinical studies with respect to risk management, and much more. Our guest today is Bijan Elahi. Bijan has worked in risk management for medical devices for over 29 years at the largest medical device companies in the world, as well as small startups. He is a technical fellow and Medtronic corporate advisor on safety risk management of. medical devices.  In this capacity, he offers education and consulting on risk management to all Medtronic business units, worldwide.  Bijan is a lecturer at Eindhoven University of Technology (Netherlands), where he teaches risk management to doctoral students in engineering. At the invitation of the FDA, he also teaches a graduate course on medical device risk management at Drexel University in Philadelphia. Bijan is the founder of MedTech Safety, Inc., an education and advisory company. He has educated over 6,500 individuals worldwide. Bijan is a frequently invited speaker at international professional conferences, and is also a contributor to ISO 14971, the international standard on the application of risk management to medical devices.  Last but not least, he is the author of Safety Risk Management for Medical Devices, published by Elsevier publishing. Enjoy! Sponsor: This podcast is brought to you by Slope. Slope provides an online eClinical Supply Chain Management (eCSCM) platform for sponsors and research sites collaborating on complex, sample-intensive, early-stage clinical trials. The Slope eCSCM platform reduces clinical trial risks, reigns in costs, improves the productivity of clinical trial collaborators, and increases subject retention by moving the manual, spreadsheet-driven, and error-prone processes used to manage and track clinical supplies and biological samples to a digital platform.  To learn more, visit slope.io and ask to speak with a solutions coordinator today.

In recognition of the 19 annual National Cyber Security Awareness Month, The Outcomes Rocket Network has launched a 10-part podcast series to elevate Cyber Security Awareness in Healthcare on our main channel, the Outcomes Rocket Podcast. Partnering with leaders in healthcare cybersecurity in their capacity as members of the Health Sector Coordinating Council, the podcast aims to illuminate advances made in protecting critical healthcare infrastructure and patient safety, and areas that need further focus to put a stop to Cyber Crime.  Chris Reed, Debra Bruemmer, and Aftin Ross talk about the Medical Device and Health IT Joint Security Plan and how it could help organizations with their work and cybersecurity gaps related to medical devices. Click this link to the show notes, transcript, and resources: outcomesrocket.health

In this episode, we talk with medtech vet Matt Franklin who left the industry. – sort of – to help lead Akili, developer of EndeavoRx, the first prescription treatment delivered through a video game. The game treats kids with ADHD, but the company has bigger plans. Chris Newmarker, executive editor of life sciences, returns with his newsmakers including CMR Surgical, Affera, Medtronic, Blackrock Neurotech, Cardinal Health, and Stryker. To hear the rest of our interview with CMR CEO Per Vergard Nerseth go here. https://www.devicetalks.com/hear-from-the-ceos-of-two-surgical-robotics-companies-that-together-just-raised-over-1-billion/ 5. https://www.massdevice.com/cmr-surgical-100-mark-versius-systems-installed/ 4. https://www.medicaldesignandoutsourcing.com/medtronic-affera-cardiac-ablation-catheter-mapping-design/ 3. https://www.massdevice.com/blackrock-neurotech-unveils-next-generation-bci-interface/ 2. https://www.massdevice.com/cardinal-health-hospital-level-care-home/ 1. https://www.massdevice.com/stryker-unveils-new-operating-room-model/ Thanks for listening to the DeviceTalks Weekly Podcast. You can subscribe to this podcast on any major podcast application.

Mia and Carla Jung are South Jersey natives and two of the most dynamic women in healthcare! These powerful twin sisters joined me fireside for a beautiful evening of conversation, sharing stories from childhood, through college at Villanova and Columbia, to their prominent positions in healthcare and finance today. A Talent Partner on the Healthcare team at WCAS, Mia focuses on executive talent strategy and management, and is responsible for helping the world's leading healthcare companies build best-in-class executive teams. Her personal mission to serve as a bridge for bringing women into private equity — specifically in healthcare — and launched "Break into the Boardroom” as her flagship initiative. The Vice President of Sales, Coronary and Renal Denervation at Medtronic, Carla leads high-performance sales teams with hundreds of members across the nation in Medtronic's pursuit to boldly attack the most challenging health problems facing humanity, with innovations that transform lives. She brings a strong passion for growing teams and transforming company cultures to the table. Enjoy!